Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) and cervical cancerCRB-701 data for both indications is expected in mid-2026 with focus on durability and patient stratificationReported 14-day CRB-913 SAD/MAD data demonstrating potent and rapid weight loss of 2.9% with favorable GI safetyOn schedule to complete 12-week CRB-913 obesity study (n=240) in summer 2026 Completed $75 million public offering in Q4 2025 extending cash ...
AerSale® Reports Fourth Quarter and Full Year 2025 Results Fourth Quarter 2025 Highlights Revenue of $90.9 million versus $94.7 million in the prior year periodGAAP net income of $5.4 million versus GAAP net income of $2.7 million in the prior year periodAdjusted net income1 of $7.5 million versus adjusted net income of $4.8 million in the prior year periodAdjusted EBITDA1 of $15.2 million versus Adjusted EBITDA of $13.0 million in the prior year periodFlight equipment sales consisted of four engines compared to six engines in the prior year periodFeedstock acquisitions of $15.4 million i...
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th. Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative. About OPKO Health OPKO is a multinational biopharmaceutic...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026. Highlights from the fourth quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This n...
UMH PROPERTIES, INC. REPORTS RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2025 FREEHOLD, NJ, Feb. 25, 2026 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income of $261.8 million for the year ended December 31, 2025 as compared to $240.6 million for the year ended December 31, 2024, representing an increase of 9%. Total Income for the quarter ended December 31, 2025 was $67.0 million as compared to $61.9 million for the quarter ended December 31, 2024, representing an increase of 8%. Net Income Attributable to Common Shareholders amounted to $6...
QNB Corp. and The Victory Bancorp, Inc. Announce Regulatory Approvals Received for Merger Quakertown, PA and Limerick, PA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- QNB Corp. ("QNB" or the "Company") (OTCQX: QNBC), the holding company for QNB Bank, and The Victory Bancorp, Inc. ("Victory") (OTCQX: VTYB), the holding company for The Victory Bank, today jointly announced that they have received all required regulatory approvals to complete their previously announced merger transaction (the “Merger”). The transaction, initially announced on September 23, 2025, is expected to close during the second ...
QNB Corp. Declares Q1 2026 Dividend Quakertown, PA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of QNB Corp. (OTCQX: QNBC), parent company of QNB Bank, at a regular meeting on February 24, declared a quarterly cash dividend of $0.39 per share. The cash dividend is payable on March 27, 2026, to shareholders of record March 13, 2026. QNB Corp. offers commercial and retail banking services through its twelve banking offices, which are operated by its subsidiary, QNB Bank, in Bucks, Montgomery, and Lehigh Counties. QNB Corp.’s stock is traded in the over-the-counter QX market...
AerSale® Announces Date for Fourth Quarter and Full Year 2025 Earnings Release Conference Call MIAMI, Feb. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ASLE) (the “Company”), announced today that it will release its earnings results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 5, 2026, after the market closes. The Company will host a conference call on the same day at 4:30 pm Eastern Time to discuss the results. A live audio webcast of the call will be available to the public on a listen‑only basis at . An archived replay of the webcast will also be availabl...
QNB Corp. and The Victory Bancorp, Inc. Announce Shareholder Approvals Received for Merger Quakertown, PA and Limerick, PA, Feb. 19, 2026 (GLOBE NEWSWIRE) -- QNB Corp. ("QNB" or the "Company") (OTCQX: QNBC), the holding company for QNB Bank, and The Victory Bancorp, Inc. ("Victory") (OTCQX: VTYB), the holding company for The Victory Bank, today jointly announced that the shareholders of both QNB and Victory have voted to approve their previously announced merger transaction (the “Merger”). The transaction, initially announced on September 23, 2025, is expected to close during the second q...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.